Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Wyeth-Ayerst and Taxolog to develop novel taxanes

July 6, 2001

Peregrine's TNT treatment shows positive results in phase I/II trial

July 5, 2001

Bradykinin B2 antagonists with anticancer activity

July 5, 2001

AEterna's Neovastat demonstrates safety and dose-related activity in prostate cancer trial

July 5, 2001

Cytovia presents new series of caspase activators and apoptosis inducers

July 4, 2001

Nippon Shinyaku to market and distribute DepoCyt in Japan

July 4, 2001

Gene and cell cycle effects elucidated for NB-1011

July 4, 2001

SafeScience to create joint venture with Elan for phase II anticancer agent

July 3, 2001

Additional beneficial effects emerge for SERM Sch-57068 (EM-652) in preclinical studies

July 3, 2001

ImClone Systems begins fast track approval process for colorectal cancer agent

July 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...